Similarly, PTT using the organic nanocomposite PLGA-ICG-R837 combined with anti-CTLA4 exerted significant suppressive effects on primary and distant tumors, followed by the generation of memory T cells and inhibition of tumor recurrence and long-term tumor-free survival [147]. The gene discussed is CTLA4; the disease is neoplasm.